Nu Skin Enterprises, Inc. (NUS) Financials
NUS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.8 billion | 984.5 million |
2023-09-30 | 1.8 billion | 970.9 million |
2023-06-30 | 1.9 billion | 998.4 million |
2023-03-31 | 1.8 billion | 931.7 million |
NUS Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 33.8 million | 3.1 million |
2023-09-30 | 39.1 million | 3.7 million |
2023-06-30 | 20.8 million | 4.8 million |
2023-03-31 | -33.6 million | 4.0 million |
NUS Net Income
Date | Net Income |
---|---|
2023-12-31 | 7.3 million |
2023-09-30 | -37.0 million |
2023-06-30 | 26.9 million |
2023-03-31 | 11.4 million |
NUS Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 267.8 million | - | 104.3 million |
2023-09-30 | 250.0 million | 362.9 million | 68.2 million |
2023-06-30 | 252.3 million | 367.8 million | 74.5 million |
2023-03-31 | 246.7 million | 372.6 million | 78.8 million |
NUS Shares Outstanding
NUS Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 20.4 million | - | 145.0 million | 181.3 million |
2023-09-30 | 11.9 million | - | 130.9 million | 187.8 million |
2023-06-30 | 14.7 million | - | 137.0 million | 185.2 million |
2023-03-31 | 11.5 million | - | 133.9 million | 188.1 million |
NUS Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 488.6 million | 136.2 million |
2023-09-30 | 498.8 million | 206.5 million |
2023-06-30 | 500.3 million | 135.5 million |
2023-03-31 | 481.5 million | 133.6 million |
NUS
Price: $12.77
Dividend Yield: 0.12%
Forward Dividend Yield: 1.90%
Payout Ratio: 17.14%
Dividend Per Share: 0.24 USD
Earnings Per Share: 0.17 USD
P/E Ratio: 12.58
Exchange: NYQ
Sector: Consumer Defensive
Industry: Household & Personal Products
Volume: 1.1 million
Ebitda: 118.2 millionMarket Capitalization: 638.8 million
Average Dividend Frequency: 4
Years Paying Dividends: 24
DGR3: 1.30%
DGR5: 1.32%
DGR10: 2.52%
DGR20: 6.95%